Franklin Biotechnology Discovery Fund

Average Annual Total Returns [further-information] As of 04/30/2020

Month EndAs of 04/30/2020 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) 18.95 6.25 2.10 15.19 11.36
Fund with Sales Charge (%) (POP) 18.95 6.25 2.10 15.19 11.36
NASDAQ Biotechnology Index (%) 16.66 7.78 2.20 15.40 11.66
S&P 500 Index (%) 0.86 9.04 9.12 11.69 7.23
Quarter EndAs of 03/31/2020 1 Yr 3 Yr 5 Yr 10 Yr Since InceptionInception 09/15/1997
Fund without Sales Charge (%) (NAV) -0.72 1.97 -1.63 13.83 10.76
Fund with Sales Charge (%) (POP) -0.72 1.97 -1.63 13.83 10.76
NASDAQ Biotechnology Index (%) -3.42 3.39 -1.17 13.82 11.02
S&P 500 Index (%) -6.98 5.10 6.72 10.53 6.69

After-Tax Average Annual Total Returns [further-information] As of 04/30/2020

Month EndAs of 04/30/2020 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold 16.63 4.95 0.62 13.73
Fund without Sales Charge (%) (NAV) After Shares Sold 12.91 4.63 1.30 12.42
Fund with Sales Charge (%) (POP) Before Shares Sold 16.63 4.95 0.62 13.73
Fund with Sales Charge (%) (POP) After Shares Sold 12.91 4.63 1.30 12.42
Quarter EndAs of 03/31/2020 1 YR 3 YR 5 YR 10 YR
Fund without Sales Charge (%) (NAV) Before Shares Sold -2.68 0.72 -3.06 12.39
Fund without Sales Charge (%) (NAV) After Shares Sold 1.33 1.48 -1.40 11.30
Fund with Sales Charge (%) (POP) Before Shares Sold -2.68 0.72 -3.06 12.39
Fund with Sales Charge (%) (POP) After Shares Sold 1.33 1.48 -1.40 11.30

Calendar Year Returns

2019 2018 2017 2016 2015 2014 2013
Fund without Sales Charge (%) (NAV) 35.35 -15.41 19.32 -16.82 5.89 34.50 69.49
Fund with Sales Charge (%) (POP) 35.35 -15.41 19.32 -16.82 5.89 34.50 69.49
NASDAQ Biotechnology Index (%) 24.41 -9.32 21.06 -21.68 11.42 34.32 65.97
S&P 500 Index (%) 31.49 -4.38 21.83 11.96 1.38 13.69 32.39

Cumulative Total Returns [further-information] As of 04/30/2020

Month EndAs of 04/30/2020 3 Month YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) 4.58 -0.16 18.95 19.96 10.96 311.20 1,040.23
Fund with Sales Charge (%) (POP) 4.58 -0.16 18.95 19.96 10.96 311.20 1,040.23
NASDAQ Biotechnology Index (%) 9.11 3.00 16.66 25.22 11.48 318.99 1,112.44
S&P 500 Index (%) -9.26 -9.29 0.86 29.66 54.74 202.21 385.18
Quarter EndAs of 03/31/2020 3 Month YTD 1 Yr 3 Yr 5 Yr 10 Yr Since Inception since 09/15/1997
Fund without Sales Charge (%) (NAV) -12.36 -12.36 -0.72 6.03 -7.91 265.20 900.93
Fund with Sales Charge (%) (POP) -12.36 -12.36 -0.72 6.03 -7.91 265.20 900.93
NASDAQ Biotechnology Index (%) -10.41 -10.41 -3.42 10.52 -5.70 265.12 954.58
S&P 500 Index (%) -19.60 -19.60 -6.98 16.11 38.47 172.10 330.05

MODERN PORTFOLIO THEORY (MPT) STATISTICSAs of 05/31/2020 (updated monthly)

3 YR 5 YR 10 YR
Standard Deviation (Fund) 24.16 25.65 23.20
Standard Deviation (NASDAQ Biotechnology Index) 22.57 24.08 21.40
Beta 1.03 1.04 1.05
Sharpe Ratio 0.44 0.04 0.74
Information Ratio 0.02 0.00 -0.01
Tracking Error 6.22 5.91 6.13

ADDITIONAL RISK STATISTICSAs of 05/31/2020 (updated monthly)

3 YR 5 YR 10 YR
Beta Bull 0.96 0.94 1.03
Beta Bear 0.93 1.00 1.02
Bull Bear Capture Ratio 1.03 1.05 1.00
Gains/Losses 1.53 1.16 1.82

SALES CHARGE, EXPENSES & FEES As of 09/01/2019 (updated annually)

Gross Expense Ratio 0.72%
Net Expense Ratio [further-information] 0.65%
Max Initial Sales Charge 0.00%
CDSC

Volatility Measures [further-information] As of 05/31/2020 Updated Monthly, based on a 3-year period

Beta 1.03
Sharpe Ratio 0.44
Standard Deviation 24.16

Benchmarks

A benchmark is a comparable broad-based index that can be used to evaluate a fund's performance.

  • NASDAQ Biotechnology Index
  • S&P 500 Index